Finally, IGF-1 treatment diminished Aβ accumulation by improving its transportation out of the brains of AD mouse models while IGF-1R inhibition aggravated both behavioral and pathological AD symptoms in mice (Carro et al., 2002, 2006). This evidence concerns the gene IGF1R and Alzheimer disease.